Asian Journal of Microbiology, Biotechnology & Environmental Sciences Paper

Vol 20, Issue 1, 2018; Page No.(82-90)

ANTIMICROBIAL RESISTANCE, BLACTX-M GENES AND GENETIC DIVERSITY OF ESCHERICHIA COLI ISOLATES FROMTAIF HOSPITALS REGION, SAUDI ARABIA

MOSTAFA M. FARAG, ALI K. ALZAHRANI, KARIM F. ABDALLAH, AYMAN K. ISMAIL, ISMAIL A. ISMAIL, FAROOQ A. GANAI AND WALAA F. ALSANIE

Abstract

Beta-lactam antibiotics have been discussed as options for the treatment of infections caused by multi resistant extended-spectrum beta-lactamase (ESBL)-producing bacteria. The objective of this study was to investigate the in vitro activity of different beta-lactam antibiotics against CTX-Mproducing Escherichia coli. Twenty isolates of 100 E. coli with the ESBL phenotype were studied. A large percentage of the E. coli was susceptible to meropenem (100%), imipenem (95%) and gentamicin (75%), but resistant to Ampicillin (95%), ceftazidime (90%) and cefepime (90%). Polymerase chain reaction (PCR) amplification of CTX-M genes was performed. These isolates were demonstrating resistance to either oxyimino-cephalosporin, and were found to harbor blaCTX-M genes by PCR. All the twenty isolates harboredbla CTX-M genes belonging to the blaCTX-M-1, blaCTX-M-2, blaCTX-M-3 and blaCTXM- 4 clusters, respectively. The antibiotics susceptibility of isolates was tested and fingerprinting of these isolates was done using fiverep-PCR primers, and Dendrogram based on rep-PCR was grouped the E. coli isolates into two different clusters with about 57% genetic similarity. The first cluster contained E. coli isolates E19 and E20, while the second cluster contained other E. coli isolates. This study shows significant differences insusceptibility to different beta-lactam antibiotics among the CTX-Mproducing E. coli isolates and a significant difference for many antibiotics tested between the CTXMproducing groups 1 and 5. The good in vitro activity of other beta-lactam antibiotics compared to carbapenems indicate that clinical studies are warranted in order to examine the potential role of these beta-lactam antibioticsin the treatment of infections caused by multiresistant ESBLproducing E. coli.

Enter your contact information below to receive full paper.
Your Name :
Email:
Phone:
City:
Cost of Full Paper: Rs.75 for Indian Nationals or $20 (USD) for international subscribers.
By clicking on Request Paper you Agree to pay the above mentioned cost per paper.
  
Journal Issues
Vol 20, Issue 2, 2018
Vol 20, Issue 1, 2018
Vol 20, Feb. Suppl. Issue, 2018
Vol 19, Issue 4, 2017
Vol 19, Nov. Suppl, Issue 2017
Vol 19, Issue 3, 2017
Vol 19, Issue 2, 2017
Vol 19, Issue 1, 2017
Vol 18, Issue 4, 2016
Vol 18, Issue 3, 2016
Vol 18, Issue 2, 2016
Vol 18, Issue 1, 2016
Vol 17, Issue 4, 2015
Vol 17, Issue 3, 2015
Vol. 17 Special Issue 2015
Vol 17, Issue 2, 2015
Vol 17, Issue 1, 2015
Vol 16, Issue 4, 2014
Vol 16, Issue 3, 2014
Vol 16, Issue 2, 2014
Vol 16, Issue 1, 2014
Vol 15, Issue 4, 2013
Vol 15, Issue 3, 2013
Vol 15, Issue 2, 2013
Vol 15 Issue 1, 2013
Vol 14, Issue 4, 2012
Vol 14, Issue 3, 2012
Vol 14, Issue 2, 2012
Vol.14, Issue 1, 2012
Vol.13, Issue 4, 2011
Vol.13, Issue 3, 2011
Vol.13, Issue 2, 2011
Vol.13, Issue 1, 2011
Vol.12, Issue 4, 2010
Vol.12, Issue 3, 2010
Vol.12, Issue 2, 2010
Vol.12, Issue 1, 2010
Vol 11, Issue 4, 2009
Vol 11, Issue 3, 2009
Vol 11, Issue 2, 2009
Vol 11, Issue 1, 2009
Vol 10, Issue 4, 2008
Vol 10, Issue 3, 2008
Vol 10, Issue 3, 2008
Vol 10, Issue 2, 2008
Vol 10, Issue 1, 2008
Vol 9, Issue 4, 2007
Vol 9, Issue 3, 2007
Vol 9, Issue 2, 2007
Vol 9, Issue 1, 2007
Vol 8, Issue 4, 2006
Vol 8, Issue 3, 2006
Vol 08, Issue 2, 2006
Vol 08, Issue 1, 2006
Vol 7 Issue 4, 2005
Vol 07, Issue 3, 2005
Vol 07, Issue 2, 2005
Vol 6 Issue 4, 2004
Vol 6 Issue 3, 2004
Vol 6 Issue 2, 2004
Vol 6 Issue 1, 2004
Vol 5 Issue 3, 2003
Vol 5 Issue 2, 2003
Vol 04, Issue 4, 2002
Vol 04, Issue 1, 2002
Vol 3 Issue 1-2, 2001
Vol 1 Issue 1-2, 2000
Vol 1 Issue 3-4, 1999
Vol 1 Issue 1-2, 1999
777
s
Looking for Past Issues? Click here to get them!!